// App-Quantinova.ai

P408 : NRAS MUTATIONS ARE INVOLVED IN ACUTE MYELOID LEUKAEMIA DRUG RESISTANCE

Researchers

Presenter

  • Fiona Healy

Principal Investigators

  • John Woolley

  • David MacEwan

Medical Centers

  • Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology,University of Liverpool,Liverpool,Vereinigtes Königreich

  • Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Bi

  • Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology,University of Liverpool,Liverpool,Vereinigtes Königreich

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • GTPase Nras

Drug/Treatment

  • gilteritinib

  • Midostaurin

  • Cytarabine liposomal

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A